Novo Nordisk is acquiring three manufacturing sites from Catalent as it seeks to keep up with patient demand for weight-loss drug Wegovy.
Source
Novo Nordisk is acquiring three manufacturing sites from Catalent as it seeks to keep up with patient demand for weight-loss drug Wegovy.
Source